week 6 fun oart 2Comprehensive GI Bowel Elimination Notes (Hospital Care)

Overview: Bowel Elimination in Hospital

• Bowel elimination involves stool color, consistency, movement, and frequency; influenced by diet, fluids, medications, surgery, and psychological factors.
• Normal elimination tends to be soft and moving regularly with adequate fluids; constipation or diarrhea signals underlying issues or interventions needed.

Key Concepts and Factors Affecting Bowel Movements

• Stool color changes due to medications or conditions:
  • Iron supplements can turn stool $ext{greenish to blackish}$.
  • Aspirin or other NSAIDs can lead to GI bleeding; stool may appear darker or have blood.
  • Pepto-Bismol can give stool a $ext{pinkish to black}$ color due to bismuth.
• Diet and hydration:
  • Adequate diet and fluids keep stool soft and moving; insufficient fiber or liquids can cause hard stool or constipation.
  • Very loose stools or diarrhea can indicate infection, prep for tests, or dietary issues.
• Psychological factors in the hospital:
  • Patients away from home may delay or avoid a bowel movement due to stress or embarrassment (e.g., fear of stool being managed by others, fear of bedpans, or fear of defecating with roommates nearby).
  • Pain, discomfort, or anxiety can reduce urge to defecate.
• Postoperative and anesthesia effects:
  • Anesthesia can slow bowel movement; abdominal surgery can cause a temporary stoppage (paralytic ileus).
  • After abdominal surgery, patients may have NG tube suction to relieve stomach secretions; nothing may move downhill for ~$24$ hours.
  • Return of bowel sounds after surgery is important to monitor; lack of bowel sounds for $24$ hours can signal ileus.
  • Pain can inhibit movement; stool softeners and fluids help;
    early ambulation is encouraged when possible to promote movement.
• Diagnostic testing and prep:
  • Diagnostic tests may require NPO (nothing by mouth) and laxative preps that cause explosive diarrhea as the bowels are cleared.
  • Preps like Go-Lytely (hydration and electrolyte-containing) are used for colonoscopy prep; another option is Supra, which uses two containers taken at different times (one at $6\,\text{PM}$ the night before; the other $\text{5 hours before}$ the procedure). Example: for an $8:00\,\text{AM}$ procedure, the second half is taken at $3:00\,\text{AM}$.
  • Go-Lytely contains electrolytes; it tastes unpleasant; others may be available.
  • If contrast is used (e.g., barium studies), milk of magnesia or similar laxatives may be given afterward to help clear the contrast.
• The GI tract and testing modalities:
  • X-ray, CT with/without contrast, ultrasound, and MRI may be used; CT with contrast or oral contrast can help visualize the GI tract; MRI is helpful for soft tissue or blood flow issues.
  • Endoscopic tests: EGD (esophagogastroduodenoscopy) and colonoscopy; biopsies may be taken.
  • Real-world limitations: routine tests may be delayed due to bed availability or discharge timing.
• Stool analysis and specimen handling:
  • Fecal occult blood testing (FOBT) and fecal immunochemical testing (FIT) detect hidden blood or markers of GI issues.
  • FOBT involves collecting stool samples from multiple locations; three samples are commonly recommended.
  • False positives can occur from red meat, NSAIDs, or Vitamin C; be mindful of patient preparation and medications.
  • Colorectal cancer screening: guidelines commonly include FIT annually; flexible sigmoidoscopy every $5$ years; colonoscopy every $10$ years starting around $45$; DNA stool testing (Cologuard) every $3$ years; newer tests like Shield blood test (ctDNA) show promise but are not universally adopted yet.
  • Calprotectin in stool is an inflammatory marker; normal < $50\ \mu g/\text{g}$; elevation to $900-1000\ \mu g/\text{g}$ can indicate active inflammation (e.g., IBD) and may prompt treatment adjustments.
  • Stool fat assessment can indicate absorption issues; require several days of collection; avoid urine contamination.
  • Stool culture and sensitivity require specific volumes (solid stool: ≈$1\ \text{inch}$; liquid stool: ≈$30\ \text{mL}$) for analysis.
  • Ova and parasites require fresh, warm specimens; delay kills organisms.
  • Fecal calprotectin is used to monitor inflammatory activity in IBD; results guide therapy decisions.
  • Contamination from urine can lead to inaccurate results; ensure proper sample collection.
• Special considerations in screening and culture:
  • Family history, race, diabetes, obesity, diet (red/processed meats), smoking, and inflammatory bowel disease increase colon cancer risk; awareness guides screening recommendations.
  • New options like the Cologuard DNA test and Shield ctDNA test provide noninvasive screening alternatives; not replacements for diagnostic colonoscopy in high-risk or positive cases.

Postoperative Bowel Management and Interventions

• Early defecation positioning:
  • Best defecation position: sitting up; if bedbound, elevate head of bed and use a bedpan to promote downward pushing.
• Stool softeners and hydration:
  • Use stool softeners; encourage fluids; maintain soft stools to ease passage, especially after hemorrhoid treatment or surgery.
• Pain management and movement:
  • Pain can inhibit movement; balancing analgesia with activity is important to avoid constipation.
• Constipation and impaction definitions:
  • Constipation: slowed bowel movements due to inactivity, opioids, low fluids, or psychological factors; not a formal medical diagnosis by itself.
  • Impaction: severe constipation with hard stool that blocks the colon; may require intervention.
• Diarrhea considerations:
  • Diarrhea can lead to rapid dehydration and electrolyte loss; identify cause (infections, prep for procedures, dietary changes, antibiotic use).
• Diarrhea management cautions:
  • Do not overuse diarrhea meds without understanding cause (e.g., Imodium) if infection is present; treat underlying cause first.
  • In Crohn’s/ulcerative colitis, avoid inducing constipation as it can irritate the colon.

Ostomies, Stomas, and Bowel Diversions

• Types and placement:
  • Bowel diversions include colostomy (colon) and ileostomy (ileum).
  • Side and location considerations: stoma should not be placed directly on belt line; mark the abdomen to place the stoma above or below belt line for comfort and to prevent leakage.
• Ostomy care and professionals:
  • Wound care/ostomy therapists (neurostomal therapists) assist with stoma management and appliance fitting.
  • Stomas can occur in adults and children; tailoring placement to activity is important.
• Pouching and appliances:
  • Pouches are typically changed every $3$ days; Medicare covers one box of $10$ pouches per $30$ days.
  • Leakage and skin breakdown occur if pouching is not performed well; skin around the stoma requires protection and barrier creams or ointments.
• Inside-the-bowel reservoir (pouch concepts):
  • Coke pouch (historical term) or Kock pouch: an internal reservoir that stores stool; requires occasional cleansing (mini enemas) to clear the reservoir; cover when not in use.
  • Managing stoma visibility and patient comfort is a key consideration in teaching and discharge planning.
• Peri-stomal care and skin integrity:
  • Proper stoma skin assessment is essential; signs of compromised blood supply (stoma turning purple or black) require urgent evaluation.
  • Ensure stoma appliance adheres properly; monitor for leakage and skin irritation; ensure adequate hydration and nutrition to support healing.
• Discharge planning and supplies:
  • When discharging, contaminated items must be taken home or disposed of properly; prepare extra supplies for at least a few days post-discharge in case home care is delayed.
• Surgical and procedural notes:
  • Enemas and other bowel-clearance techniques may be used in patients with ostomies or prior to stoma creation to ensure clean operative fields.

Enemas and Bowel Clearance Techniques

• Indications and patient involvement:
  • Enemas are used to clear the bowel; some patients can perform enemas themselves if oriented and dexterous; others require assistance.
  • Lubrication and gentle technique are crucial to prevent mucosal injury; monitor patient comfort and vital signs.
• Enema types and volumes:
  • Small-volume hypertonic enemas (high osmolarity) require less volume but are concentrated.
  • Large-volume enemas: ~$1000\ \text{mL}$; used for complete cleansing or specific prep (e.g., colonoscopy).
  • Isotonic (tap water) enemas: hypotonic; require careful administration due to potential shifts in fluid balance.
  • Soap suds enemas using Castile soap (avoid harsh soaps) for irritation-free cleansing.
  • Oil retention enemas: oil-based; help lubricate stool to ease passage; may be used to facilitate stool movement.
• Special agents:
  • KAXALATE: resin binder that binds potassium in the gut to reduce serum potassium; used in hyperkalemia; enema form can help clear potassium via stool.
  • K-oxalate: oral slurry enema that binds potassium similarly; used when dialysis access is limited.
  • Neomycin enema: antibiotic enema used preoperatively to reduce gut bacterial load and infection risk during surgery.
• Procedural considerations:
  • Positioning: left lateral Sims position to facilitate enema flow along the colon (descending colon on the left side).
  • Monitor vitals (pulse, blood pressure) and adjust pace/dose if patient experiences bradycardia or pain.
  • Complete administration to ensure full effect; if needed, additional enemas may be given but typically not beyond 3 attempts (maximum ~$3$).
  • PEG/NG tubes: if needed for gastric decompression, ensure device patency and monitor for mucosal irritation.
• Safety and technique:
  • Use clean technique; maintain sterile or clean conditions as appropriate; avoid contaminating the sterile field.
  • If the patient is fully immobilized, assistance from a nurse is necessary for enema administration.
  • Monitor for adverse effects and pause if patient reports pain or inability to tolerate procedure.

Diagnostic Imaging and Laboratory Assessments

• Stool testing and lab work:
  • CBC to assess for anemia if there is suspected GI bleeding.
  • Stool tests for occult blood (FOBT) and FIT; three samples commonly collected; testing involves applying stool to a card or inserting into a developer solution.
  • Color interpretation in FOBT can be challenging for color-blind individuals; blue color indicates a positive test; ensure competency and confirm with lab results.
  • False positives can occur due to recent red meat intake, NSAID use, or vitamin C supplementation; patient education is essential.
  • Stool cultures and sensitivity require fresh stool samples; avoid urine contamination; ensure timely transport to the lab.
  • Ova and parasites require fresh, warm specimens; delays lead to organism death and inaccurate results.
  • Fecal calprotectin: inflammatory marker; normal < $50\ \mu g/\text{g}$; elevated levels (e.g., $900-1000\ \mu g/\text{g}$) suggest active inflammation; guide treatment decisions such as steroids.
  • Stool fat testing may be ordered for malabsorption evaluation; requires multiple days of collection.
  • For imaging, plain X-ray has limited soft tissue detail; CT with contrast or MRI may provide better information for soft tissues or vascular issues.
• Procedures and their role:
  • Colonoscopy: gold standard for direct visualization and biopsy; requires thorough bowel prep to maximize mucosal visibility.
  • EGD: visualizes esophagus, stomach, and duodenum; biopsies may be taken.
  • CT/MRI: used when anatomy or pathology is not well defined by X-ray or ultrasound alone.
• Practical notes for hospital workflow:
  • Routine diagnostic testing may be delayed due to bed availability or patient discharge timing; plan accordingly.

Intake, Output, and Patient Monitoring

• Intake and output (I&O) concepts:
  • Intake includes all liquids entering the body; beverages, Jell-O, ice cream (counted as liquid at room temperature).
  • Ice is counted at roughly 50% of its volume toward intake: $ext{effective ice intake} = 0.5 imes V_{ ext{ice}}$.
  • Output includes urine and stool; monitor differences to assess hydration status and GI function.
• Urine collection devices:
  • Urine hats and bedside devices collect urine in bedbound or bedpan situations; separate stool collection from urine when necessary to avoid contamination.
  • When measuring urine, ensure to note color, clarity, and odor; consider urine testing if indicated.
• Specimen handling tips:
  • For stool specimens, avoid urine contamination; for urine specimens, avoid stool contamination.
  • Use graduated cylinders for accurate liquid measurement; basic bedside devices may be less precise.

Colorectal Cancer Screening: Guidelines and Emerging Tests

• Risk factors and warning signs:
  • Age is a major risk factor; family history; history of polyps; inflammatory bowel disease.
  • Diets high in red and processed meats; obesity; smoking; type 2 diabetes; race/ethnicity can influence risk.
  • Early warning signs include changes in bowel habits, blood in stools, abdominal pain, and unintentional weight loss.
• Screening options and intervals:
  • Fecal tests (FOBT or FIT) annually; do at home or in clinic as directed.
  • Flexible sigmoidoscopy every $5$ years (limited to sigmoid colon).
  • Colonoscopy every $10$ years starting at about $45$ (full visualization and biopsies possible).
  • DNA stool test (Cologuard) every $3$ years as an alternative for average-risk individuals who decline colonoscopy.
  • Consider age adjustments: for average-risk individuals, screening often from $45$ to $75$; after $75$, decisions are individualized; after $85$, invasive screening is generally not recommended.
• Newer screening options:
  • Shield blood test (ctDNA) as a blood-based screening that detects genetic material from colon cancer; about 90 ext{%} accuracy in some settings; not universally adopted yet.
• Practical notes:
  • For the home-based tests, follow instructions precisely (e.g., avoid contamination by urine, store samples properly, and mail with provided materials).
  • Healthcare providers may tailor screening recommendations based on personal and family history, comorbidities, and patient preferences.

Practical Nursing Considerations and Safety

• Multidisciplinary care:
  • Nursing diagnoses related to altered bowel elimination require collaboration with physicians, dietitians, and other licensed personnel to delegate tasks and coordinate care.
  • Peri-care and hygiene are essential, especially for ostomy patients; maintain skin integrity with barrier products.
• Cultural and ethical considerations:
  • Be sensitive to privacy and cultural practices around elimination, sexuality, and body image; approach care respectfully and with consent.
• Patient education and discharge planning:
  • Provide comprehensive ostomy care education to patients and families; discuss appliance changes, care routines, and alarm signs for complications.
  • When discharging, ensure supplies (pouches, tape, dressings) are available and explain ordering processes for home care equipment.
  • Encourage patients to sit on the toilet when possible and to maintain regular elimination habits to promote GI motility.
• Safety precautions:
  • Always wear gloves when handling stool, urine, specimens, or peri-care.
  • Be mindful of exposure to blood in stool; practice universal precautions and report any bleeding or contamination concerns promptly.

Quick Reference: Clinical Scenarios and Exam-Style Questions

• Why defecate about one hour after meals? After eating, peristalsis is stimulated; an approximate window for the urge to defecate occurs about $1\ \text{hour}$ after meals.
• If antidiarrheal medications are used extensively, what electrolyte issue might occur? Potential hypokalemia due to stool losses; monitor potassium levels.
• Should salt tablets be routinely used to increase extracellular solute concentration? No; they can disrupt fluid and electrolyte balance.
• Do bulk-forming laxatives always discolor urine? No; bulk-forming agents do not inherently cause urine to turn pink.
• When a patient has a new ostomy, what are key monitoring signs for urgent action? Stoma that turns purple/black or skin breakdown around the stoma — urgent assessment and intervention are needed.

Practical Takeaways for Exam Preparation

• Be able to differentiate constipation, diarrhea, and impaction; know signs, management principles, and escalation triggers.
• Understand the purpose and sequence of bowel prep for colonoscopy and alternative options (e.g., Supra) and their practical timing.
• Recognize the roles of different ostomy types (colostomy vs ileostomy) and key considerations for appliance fitting, skin care, and teach-back to patients.
• Recall screening intervals and the rationale behind each test type (FOBT/FIT, flexible sigmoidoscopy, colonoscopy, Cologuard, Shield ctDNA).
• Be prepared to discuss enema types, volumes, indications, safety considerations, and patient involvement; know when to advance beyond basic enemas.
• Maintain awareness of I&O calculations, including how to count intake from beverages, Jell-O, and ice (with ice counting as 50%), and how to document output accurately.
• Appreciate the emotional and psychological aspects of bowel care in hospitalized patients and strategies to maintain dignity and cooperation.

Final Notes

• The GI system is highly variable between patients; treatment and assessment require a patient-centered, multidisciplinary approach.
• When in doubt, prioritize patient safety, avoid invasive procedures without clear indication, and ensure proper sample collection and documentation for accurate test results.
• Stay current with evolving screening modalities (e.g., DNA/methylation-based tests) and tailor recommendations to individual risk profiles and preferences.